當(dāng)前位置：首頁 > 資料下載 > cellmosaic 2026年終端采購售價清單-上海起發(fā)

cellmosaic 2026年終端采購售價清單-上海起發(fā)

發(fā)布時間：2025/12/10 點(diǎn)擊次數(shù)：406

美國Cell Mosaic公司是一家專注于生物偶聯(lián)技術(shù)領(lǐng)域的創(chuàng)新型生物技術(shù)企業(yè)，自2008年成立以來，始終致力于推動生物偶聯(lián)技術(shù)的邊界，為生物醫(yī)藥研發(fā)提供關(guān)鍵工具與服務(wù)。公司總部位于美國馬薩諸塞州的伍本（Woburn, MA），由一位在偶聯(lián)技術(shù)領(lǐng)域擁有深厚興趣和豐富經(jīng)驗的黃博士（Dr. Huang）創(chuàng)立，公司規(guī)模雖屬中小型（約2-10名員工），但其技術(shù)影響力已輻射至多個地區(qū)。

Cell Mosaic的核心定位是為生物醫(yī)藥、診斷試劑及基礎(chǔ)科研領(lǐng)域提供高效、安全的生物偶聯(lián)解決方案。其使命是“通過創(chuàng)新技術(shù)加速生物偶聯(lián)物開發(fā)"。生物偶聯(lián)物是一類重要的生物分子，被廣泛用作研究工具、診斷試劑以及新型治療藥物的載體，其中最引人注目的應(yīng)用便是抗體藥物偶聯(lián)物（ADC）。公司通過其專有的技術(shù)平臺，服務(wù)于包括制藥公司、生物技術(shù)企業(yè)、學(xué)術(shù)研究機(jī)構(gòu)在內(nèi)的超過500家客戶。

在技術(shù)層面，Cell Mosaic的核心競爭力主要體現(xiàn)在其兩大技術(shù)平臺：個性化偶聯(lián)試劑盒（PerKit®）和AqueaTether™（AqT®）連接劑平臺。PerKit®系列產(chǎn)品是Cell Mosaic特色的解決方案，它旨在滿足研究人員對生物偶聯(lián)的個性化需求。與傳統(tǒng)標(biāo)準(zhǔn)化的試劑盒不同，PerKit®的理念是“為每一類分子量身定制"。它允許研究人員在自家實驗室內(nèi)，利用Cell Mosaic經(jīng)過驗證的工藝，高效地制備出高質(zhì)量的生物偶聯(lián)物。該系列試劑盒覆蓋范圍廣泛，能夠?qū)崿F(xiàn)抗體（IgG或F(ab")2片段）、蛋白質(zhì)與多種小分子藥物（如Doxorubicin、Methotrexate、MMAE/MMAF、SN-38、Deruxtecan等）的偶聯(lián)。其操作流程經(jīng)過優(yōu)化，大部分偶聯(lián)工作可在一天內(nèi)完成，手動操作時間少于2小時，且最終產(chǎn)物的純度可達(dá)90%以上，大大降低了ADC藥物研發(fā)的門檻。

AqT®連接劑平臺則代表了Cell Mosaic在連接劑設(shè)計上的前沿創(chuàng)新。這是一種由天然、可食用的糖醇（Sugar Alcohol）化合物化學(xué)組裝而成的新型連接劑。其在結(jié)構(gòu)上類似于常用的聚乙二醇（PEG），但在親水性、負(fù)載能力、功能多樣性和易于定制方面展現(xiàn)出潛在優(yōu)勢。當(dāng)用于ADC藥物開發(fā)時，AqT®連接劑能有效改善疏水性藥物與抗體偶聯(lián)后容易聚集沉淀的問題，顯著提高ADC藥物的穩(wěn)定性、均一性和生物相容性，從而有望降低藥物毒性，提升治療效果。Cell Mosaic在該領(lǐng)域擁有強(qiáng)大的知識產(chǎn)權(quán)布局，是范圍內(nèi)涉足糖醇化合物用于生物偶聯(lián)的優(yōu)秀者。

除了核心產(chǎn)品線，Cell Mosaic還提供豐富的定制化服務(wù)?；谄渖詈竦呐悸?lián)技術(shù)積累，公司為客戶提供定制偶聯(lián)服務(wù)，截至2017年已成功交付超過150個項目，生產(chǎn)了100多種獨(dú)特的偶聯(lián)物。此外，公司還開發(fā)了諸如oxLink™、sxLink™（用于研究蛋白質(zhì)-蛋白質(zhì)相互作用）和NeIon™（用于質(zhì)譜檢測和定量痕量分析物）等一系列輔助技術(shù)平臺，進(jìn)一步擴(kuò)展了其在生命科學(xué)分析工具領(lǐng)域的能力。

在業(yè)務(wù)模式上，Cell Mosaic覆蓋了從核心試劑與試劑盒供應(yīng)、定制化偶聯(lián)服務(wù)到合同開發(fā)與制造（CDMO）合作的全流程支持。其產(chǎn)品線不僅包括偶聯(lián)試劑盒，還提供各種預(yù)制的藥物偶聯(lián)物對照品、ADC穩(wěn)定存儲緩沖液、HPLC分析緩沖液、標(biāo)準(zhǔn)品以及各種分析試劑盒，為ADC藥物的研發(fā)提供了全面的解決方案。

為了更貼近市場，Cell Mosaic積極布局國際化網(wǎng)絡(luò)，在中國等地區(qū)設(shè)立了分支機(jī)構(gòu)總代理，例如艾美捷科技有限公司（AmyJet Scientific Inc.）和達(dá)科為等，通過本地化團(tuán)隊為客戶提供快速響應(yīng)的技術(shù)支持、產(chǎn)品銷售和供應(yīng)鏈服務(wù)。這表明其致力于將技術(shù)更直接地服務(wù)于快速增長的區(qū)域市場。

綜上所述，美國Cell Mosaic生物公司憑借其在生物偶聯(lián)領(lǐng)域，特別是ADC藥物開發(fā)方面的一系列創(chuàng)新性技術(shù)平臺和產(chǎn)品，成功地在精準(zhǔn)醫(yī)療和生物醫(yī)藥研發(fā)領(lǐng)域占據(jù)了獨(dú)特而重要的位置。其以PerKit®和AqT®為代表的核心技術(shù)，不僅為科學(xué)家提供了強(qiáng)大的研究工具，也為其在下一代生物治療藥物的開發(fā)合作中奠定了堅實基礎(chǔ)。

關(guān)鍵詞：cellmosaic，cellmosaic上海代理，cellmosaic中國代理，cellmosaic北京代理，cellmosaic江蘇代理， cellmosaic廣東代理、CellMosaic 生物偶聯(lián)技術(shù)，ADC抗體藥物偶聯(lián)物，AqT連接劑，PerKit試劑盒，抗體藥物偶聯(lián)試劑，蛋白偶聯(lián)技術(shù)，ADC藥物開發(fā)，生物偶聯(lián)服務(wù)，CellMosaic中國代理，糖醇聚合物載體，ADC穩(wěn)定性解決方案，抗體偶聯(lián)工藝，定制化生物偶聯(lián)，疏水藥物遞送，抗體藥物研發(fā)工具，細(xì)胞 mosaic 技術(shù)平臺，生物偶聯(lián)專家，ADC藥物創(chuàng)新，蛋白質(zhì)標(biāo)記技術(shù)，生物醫(yī)藥研發(fā)材料。

特別告知：為保證產(chǎn)品質(zhì)量與良好性能，所以在購買相應(yīng)產(chǎn)品的同時我司會收取一定量的運(yùn)輸費(fèi)用?。。”敬螆髢r有效時間為2025年12月10日---2026年12月14日。

（*此為部分產(chǎn)品價格,完整價格請下載文件）

貨號	品名	規(guī)格	價格	品牌
CM51103-100UG	ADC Control hIgG1-Deruxtecan 100UG	100microgram	10948	cellmosaic
CM51103-500UG	ADC Control hIgG1-Deruxtecan 500UG	500microgram	34168.8	cellmosaic
CM51103-1MG	ADC Control hIgG1-Deruxtecan 1MG	2x500UG	46294.4	cellmosaic
CM51100-100UG	ADC Control hIgG1-MMAE 100UG	100microgram	10948	cellmosaic
CM51100-1MG	ADC Control hIgG1-MMAE 1MG	1MG	46294.4	cellmosaic
CM51100-500UG	ADC Control hIgG1-MMAE 500UG	500Microgram	32549.6	cellmosaic
CM51101-100UG	ADC Control hIgG1-MMAF with VC-PAB Linker 100UG	100microgram	10948	cellmosaic
CM51101-1MG	ADC Control hIgG1-MMAF with VC-PAB Linker 1MG	2x500UG	46294.4	cellmosaic
CM51101-500UG	ADC Control hIgG1-MMAF with VC-PAB Linker 500UG	500microgram	32549.6	cellmosaic
CM51104-100UG	ADC Control hIgG1-PBD Dimer 100UG	100microgram	11610.4	cellmosaic
CM51104-1MG	ADC Control hIgG1-PBD Dimer 1MG	2x500microgram	49312	cellmosaic
CM51104-500UG	ADC Control hIgG1-PBD Dimer 500UG	500microgram	34500	cellmosaic
CM51102-100UG	ADC Control hIgG1-SN38 100UG	packed 1x100UG in Box (S1)	10948	cellmosaic
CM51102-1MG	ADC Control hIgG1-SN38 1MG	2x500microgram	46294.4	cellmosaic
CM51102-500UG	ADC Control hIgG1-SN38 500UG	2x500microgram	32549.6	cellmosaic
CM11429x1	ADC Control Kit with VC-PAB Linker, 1 reaction	1Reaction	11739.2	cellmosaic
CM11429x3	ADC Control Kit with VC-PAB Linker, 3 reaction	3Reaction	29092.8	cellmosaic
CM02025-1L	ADC HIC HPLC Analysis Buffer Set 1L	1	16063.2	cellmosaic
CM02025-250ML	ADC HIC HPLC Analysis Buffer Set 250 ML	1	5832.8	cellmosaic
CM02023	ADC Stabilizing Citrate buffer (5x)	10mL	3845.6	cellmosaic
CM02024	ADC Stabilizing General Buffer (5x)	10mL	3845.6	cellmosaic
CM02022	ADC Stabilizing PBS buffer (5x)	10mL	3845.6	cellmosaic
CM29101-1ML	Alprenolol-sepharose 1ML	1mL	5501.6	cellmosaic
CM29101-25ML	Alprenolol-sepharose 25ML	25mL	71760	cellmosaic
CM29101-5ML	Alprenolol-sepharose 5ML	5mL	21252	cellmosaic
CM29305-5MG	Ang 1-7 5MG	5mg	1656	cellmosaic
CM29305-25MG	Ang 1-7 25MG	25mg	3680	cellmosaic
CM29301-25MG	Ang I (1-10) 25 MG	25mg	3680	cellmosaic
CM29301-5MG	Ang I (1-10) 5MG	5mg	1656	cellmosaic
CM29302-25MG	Ang II (1-8) 25MG	25mg	3220	cellmosaic
CM29302-5MG	Ang II (1-8) 5MG	5mg	1656	cellmosaic
CM29303-25MG	Ang III (2-8) 25MG	25mg	2208	cellmosaic
CM29303-5MG	Ang III (2-8) 5MG	5mg	1656	cellmosaic
CM29304-25MG	Ang IV (human) 25MG	25mg	2760	cellmosaic
CM29304-5MG	Ang IV (human) 5MG	5mg	1656	cellmosaic
CM11431.01x1	Antibody Deruxtecan Conjugation Kit 0.1 mg 1 reaction	1Reaction	20504	cellmosaic
CM11431.01x3	Antibody Deruxtecan Conjugation Kit 0.1 mg 3 reactions	1Reaction	49878.4	cellmosaic
CM11431x1	Antibody Deruxtecan Conjugation Kit 1 Reaction	1Reaction	25220.8	cellmosaic
CM11431x3	Antibody Deruxtecan Conjugation Kit 3 Reactions	3Reactions	60068.8	cellmosaic
CM11434x1	Antibody Deruxtecan High Loading Conjugation Kit 1 Reaction	1Reaction	27315.2	cellmosaic
CM11434x3	Antibody Deruxtecan High Loading Conjugation Kit 3 Reactions	3Reactions	64240	cellmosaic
CM11406x1	Antibody Doxorubicin Conjugation Kit 1 Reaction	1Reaction	20961.6	cellmosaic
CM11406x3	Antibody Doxorubicin Conjugation Kit 3 Reactions	3Reactions	49878.4	cellmosaic
CM11422x1	Antibody Mc-MMAF Conjugation Kit 1 Reaction	1Reaction	25220.8	cellmosaic
CM11422x3	Antibody Mc-MMAF Conjugation Kit 3 Reactions	3Reactions	60068.8	cellmosaic
CM11410.01x1	Antibody Mertansine (DM1) Conjugation Kit 0.1 mg 1 Reaction	1Reaction	17054.4	cellmosaic
CM11410.01x3	Antibody Mertansine (DM1) Conjugation Kit 0.1 mg 3 reactions	3Reactions	38808	cellmosaic
CM11410x1	Antibody Mertansine (DM1) Conjugation Kit 1 Reaction	1Reaction	20961.6	cellmosaic
CM11410x3	Antibody Mertansine (DM1) Conjugation Kit 3 reactions	3Reactions	49878.4	cellmosaic
CM11407x1	Antibody Methotrexate Conjugation Kit 1 Reaction	1Reaction	20961.6	cellmosaic
CM11407x3	Antibody Methotrexate Conjugation Kit 3 Reactions	3Reactions	49878.4	cellmosaic
CM11409.01x1	Antibody MMAE Conjugation Kit (with VC-PAB Linker) 0.1 mg 1 reaction	1Reaction	17054.4	cellmosaic
CM11409.01x3	Antibody MMAE Conjugation Kit (with VC-PAB Linker) 0.1 mg, 3 reactions	3Reactions	38808	cellmosaic
CM11409x1	Antibody MMAE Conjugation kit (with VC-PAB Linker) 1 reaction	1Reaction	20961.6	cellmosaic
CM11409x3	Antibody MMAE Conjugation Kit (with VC-PAB Linker) 3 Reactions	3Reactions	49878.4	cellmosaic
CM11425x1	Antibody MMAF conjugation kit (with VC-PAB linkage) 1 reaction	1Reaction	25220.8	cellmosaic
CM11425x3	Antibody MMAF conjugation kit (with VC-PAB linkage) 3 reactions	3Reactions	60068.8	cellmosaic
CM11435x1	Antibody or Protein Exatecan Conjugation Kit 1 Reaction	1Reaction	25220.8	cellmosaic
CM11436x1	Antibody or Protein Exatecan Conjugation Kit with VC-PAB Linker, 1 Reaction	1Reaction	25220.8	cellmosaic
CM11436x3	Antibody or Protein Exatecan Conjugation Kit with VC-PAB Linker, 3 Reactions	1Reaction	60068.8	cellmosaic
CM11439x1	Antibody or Protein PBD Dimer Conjugation Kit with Val-Ala Linker, 1 Reaction	1Reaction	26400	cellmosaic
CM11439x3	Antibody or Protein PBD Dimer Conjugation Kit with Val-Ala Linker, 3 Reactions	1Reaction	63360	cellmosaic
CM11438x1	Antibody or Protein SN38 Conjugation Kit with VC-PAB Linker, 1 Reaction	1Reaction	20961.6	cellmosaic
CM11439.01x1	Antibody PBD Dimer Conjugation Kit with Val-Ala Linker, 0.1 mg 1 reaction	1Reaction	22704	cellmosaic
CM11439.01x3	Antibody PBD Dimer Conjugation Kit with Val-Ala Linker, 0.1 mg 3 reactions	1Reaction	51955.2	cellmosaic
AS1004	Antibody PerKit™ Customization for 1-3 mg none IgG Type Antibody	1	3937.6	cellmosaic
CM11408x1	Antibody SN38 Conjugation Kit 1 Reaction	1Reaction	20961.6	cellmosaic
CM11408x3	Antibody SN38 Conjugation Kit 3 Reactions	3Reactions	49878.4	cellmosaic
CM11433x1	Antibody UM171 Conjugation Kit 1 Reaction	1Reaction	25924.8	cellmosaic
CM11433x3	Antibody UM171 Conjugation Kit 3 Reactions	1Reaction	61723.2	cellmosaic
CM53405.3x1	Antibody-Oligo Conjugation Kit, ≥60 bases, 1 reaction	1Reaction	12883.2	cellmosaic
CM53405.3x3	Antibody-Oligo Conjugation Kit, ≥60 bases, 3 reactions	3Reactions	30518.4	cellmosaic
CM53405.2x1	Antibody-Oligo Conjugation Kit, 31-59 bases, 1 reaction	1Reaction	11897.6	cellmosaic
CM53405.2x3	Antibody-Oligo Conjugation Kit, 31-59 bases, 3 reactions	3Reactions	27843.2	cellmosaic
CM53405.1x1	Antibody-Oligo Conjugation Kit, 5-30 bases, 1 reaction	1Reaction	11897.6	cellmosaic
CM53405.1x3	Antibody-Oligo Conjugation Kit, 5-30 bases, 3 reactions	3Reactions	27843.2	cellmosaic
CM86140.4x3	AqT™ Biotin Active Ester Antibody Labeling Kit (T2A15) 1 mg Scale, 3 Reactions	ea	28776	cellmosaic
CM86101	AqT™ Biotin Goat Anti-Human IgG, Fcγ Fragment Specific	Packed in 100 ug per tube	4379.2	cellmosaic
CM61002-10MG	Biotin-Alprenolol Conjugate 10MG	10mg	47177.6	cellmosaic
CM61002-1MG	Biotin-Alprenolol Conjugate 1MG	1mg	10156.8	cellmosaic
CM61002-5MG	Biotin-Alprenolol Conjugate 5MG	5mg	33046.4	cellmosaic
CM61008-1MG	Biotin-d(PEG)2-Preladenant Conjugate 1 mg	1mg	13800	cellmosaic
CM61008-10MG	Biotin-d(PEG)2-Preladenant Conjugate 10x1 mg	1mg	77905.6	cellmosaic
CM61008-5MG	Biotin-d(PEG)2-Preladenant Conjugate 5x1 mg	1mg	48686.4	cellmosaic
CM52132-0.5MG	BSA Creatine L8 0.5 mg	0.5mg	20460.8	cellmosaic
CM52117-0.5MG	BSA Creatinine L8 0.5 mg	1mg	16946.4	cellmosaic
CM52117-1MG	BSA Creatinine L8 1 mg	1mg	27121.6	cellmosaic
CM52117-5MG	BSA Creatinine L8 5x1 mg	5x1mg	113160	cellmosaic
CM92006	BSA Standard for Protein Quantitation	1Pack	3845.6	cellmosaic
CM52140-1MG	BSA-Deruxtecan Conjugate 1 mg	1mg	11592	cellmosaic
CM52140-5MG	BSA-Deruxtecan Conjugate 5 mg	1mg	40976.8	cellmosaic
CM52107-1MG	BSA-Digoxigenin 1MG	1mg	12898.4	cellmosaic
CM52107-5MG	BSA-digoxigenin 5x1MG	5x1mg	43773.6	cellmosaic
CM52110-1MG	BSA-DM1 (Mertansine) conjugate 1MG	1mg	10359.2	cellmosaic
CM52110-5MG	BSA-DM1 (Mertansine) conjugate 5x1MG	5x1mg	34316	cellmosaic
CM52112-1MG	BSA-DM4 (Ravtansine) Conjugate 1MG	1mg	11702.4	cellmosaic
CM52112-5MG	BSA-DM4 (Ravtansine) Conjugate 5x1MG	5x1mg	41455.2	cellmosaic
CM52113-1MG	BSA-MMAE Conjugate 1 mg	1mg	11389.6	cellmosaic
CM52113-5MG	BSA-MMAE Conjugate 5x1 mg	5x1mg	40976.8	cellmosaic
CM52149-1MG	BSA-SN38 Conjugate 1 mg	1mg	11592	cellmosaic
CM52149-5MG	BSA-SN38 Conjugate 5 mg	5x1mg	40976.8	cellmosaic
CM53214-1x2MG	C6 Maleimide Activated HRP 2MG	2mg	3220	cellmosaic
CM53214-3x2MG	C6 Maleimide Activated HRP 3x2MG	3x2mg	7967.2	cellmosaic
CM52135-1MG	Ciprofloxacin-BSA Conjugate ML 1MG	ea	10304	cellmosaic
CM52135-5MG	Ciprofloxacin-BSA Conjugate ML 5x1 MG	ea	38952.8	cellmosaic
CM16001	Curcumin-beta-D-Glucuronide MS Standard	100microgram	3845.6	cellmosaic
CM62106-100MG	Cyanine 5.5 Polysucrose-400	100MG	3588	cellmosaic
CM62106-500MG	Cyanine 5.5 Polysucrose-400	500MG	14352	cellmosaic
CM62105-100MG	Cyanine 7 Polysucrose-400	100MG	3588	cellmosaic
CM62105-500MG	Cyanine 7 Polysucrose-400	500MG	14352	cellmosaic
CM11035.1	Exatecan Control Set for In Vitro Studies	ea	3220	cellmosaic
CM11419x1	F(ab')2 Mertansine (DM1) Conjugation Kit 1 reaction	1Reaction	20961.6	cellmosaic
CM11419x3	F(ab')2 Mertansine (DM1) Conjugation Kit 3 reactions	3Reactions	49878.4	cellmosaic
CM11416x1	F(ab')2 MMAE Conjugation Kit (With VC-PAB Linkage) 1 reaction	1Reaction	20961.6	cellmosaic
CM11416x3	F(ab')2 MMAE Conjugation Kit (With VC-PAB Linker) 3 reactions	3Reactions	49878.4	cellmosaic
CM62102-10MG	Fluorescein-Doxorubicin Conjugate 10MG	10mg	21546.4	cellmosaic
CM62102-1MG	Fluorescein-Doxorubicin Conjugate 1MG	1mg	3808.8	cellmosaic
CM62102-5MG	Fluorescein-Doxorubicin Conjugate 5MG	5mg	12548.8	cellmosaic
CM92007	HIC Standard for Column Performance	1Pack,4components	3845.6	cellmosaic
CM51406x1	HRP Antibody Conjugation Kit 1 Reaction	1Reaction	12249.6	cellmosaic
CM53408.2x1	HRP Oligo Conjugation Kit (Single Label with Thiol Oligo), ≥31 bases, 1 reaction	1Reaction	6881.6	cellmosaic
CM53408.2x3	HRP Oligo Conjugation Kit (Single Label with Thiol Oligo), ≥31 bases, 3 reactions	3Reaction	15752	cellmosaic
CM53408.1x1	HRP Oligo Conjugation Kit (Single Label with Thiol Oligo), 5-30 bases, 1 reaction	1Reaction	6881.6	cellmosaic
CM53408.1x3	HRP Oligo Conjugation Kit (Single Label with Thiol Oligo), 5-30 bases, 3 reactions	3Reaction	15752	cellmosaic
CM51406x3	HRP-Antibody Conjugation Kit 3 Reactions	3Reactions	28617.6	cellmosaic
CM53215-0.5MG	HRP-Deruxtecan (Dxd) (1:1) Conjugate, 0.5MG	0.5MG	12199.2	cellmosaic
CM53215-2MG	HRP-Deruxtecan (Dxd) (1:1) Conjugate, 2MG	0.5MGX4	39560	cellmosaic
CM53209-0.5MG	HRP-MMAE (1:1) Conjugate, 0.5MG	0.5MG	11610.4	cellmosaic
CM53209-2MG	HRP-MMAE (1:1) Conjugate, 2MG	4x0.5MG	37940.8	cellmosaic
CM53210-0.5MG	HRP-MMAE (1:2) Conjugate, 0.5MG	0.5MG	11610.4	cellmosaic
CM53210-2MG	HRP-MMAE Conjugate (1:2), 2MG	4x0.5MG	37940.8	cellmosaic
CM53216-0.5MG	HRP-MMAF (1:1) Conjugate, 0.5MG	0.5MG	12199.2	cellmosaic
CM53216-2MG	HRP-MMAF (1:1) Conjugate, 2MG	2MG	39560	cellmosaic
CM53407.3x1	HRP-Oligo Conjugation Kit (Single Label with Amine Oligo), ≥60 bases, 1 reaction	1Reaction	7902.4	cellmosaic
CM53407.3x3	HRP-Oligo Conjugation Kit (Single Label with Amine Oligo), ≥60 bases, 3 reactions	3Reactions	18110.4	cellmosaic
CM53407.2x1	HRP-Oligo Conjugation Kit (Single Label with Amine Oligo), 31-59 bases, 1 reaction	1Reaction	6881.6	cellmosaic
CM53407.2x3	HRP-Oligo Conjugation Kit (Single Label with Amine Oligo), 31-59 bases, 3 reactions	3Reactions	15752	cellmosaic
CM53407.1x1	HRP-Oligo Conjugation Kit (Single Label with Amine Oligo), 5-30 bases, 1 reaction	1Reaction	6881.6	cellmosaic
CM53407.1x3	HRP-Oligo Conjugation Kit (Single Label with Amine Oligo), 5-30 bases, 3 reactions	3Reactions	15752	cellmosaic
CM53202-100UG	HRP-Streptavidin (1:1) Conjugate, 100 Microgram	1tube	5814.4	cellmosaic
CM53202-500UG	HRP-Streptavidin (1:1) Conjugate, 500 Microgram	1tube	18013.6	cellmosaic
CM53217-0.5MG	HRP-VC-PAB-MMAF (1:1) Conjugate, 0.5MG	0.5MG	12199.2	cellmosaic
CM53217-2MG	HRP-VC-PAB-MMAF (1:1) Conjugate, 2MG	2MG	39560	cellmosaic
CM52108-1MG	KLH-digoxigenin 1MG	1mg	16228.8	cellmosaic
CM52108-5MG	KLH-digoxigenin 5x1MG	5mg	54758.4	cellmosaic
CM63401	Light and Heavy Quaternary Amine MS Labeling Kit for Carboxylic Acid	1	4876	cellmosaic
CM52111-1x2MG	Maleimide Activated BSA HL 2MG	2mg	2539.2	cellmosaic
CM52111-3x2MG	Maleimide Activated BSA HL 3x2MG	3x2mg	6127.2	cellmosaic
CM52145-1x2MG	Maleimide Activated BSA LL 2MG	2mg	2539.2	cellmosaic

文件下載

上一篇：2025年12月現(xiàn)貨產(chǎn)品清單-上海起發(fā)
下一篇：Gracebio 2026年終端采購售價清單-上海起發(fā)